Oxford spinout Semmle has been acquired by GitHub, a subsidiary of Microsoft, providing exits to investors including Accel that had supplied $31m in funding.

Fosun-backed Shanghai Henlius Biotech has priced shares at the bottom of its range to raise $410m in its initial public offering ahead of public trading next week.

Haldor Topsøe remains the largest shareholder of cancer treatment developer IGM Biosciences, whose shares have risen more than 50% since it floated yesterday.

Lundbeck, Pfizer and Alexandria Real Estate Equities are all in line for exits after Imara revealed it has confidentially filed for an initial public offering.

Monthly analysis: July-August 2019

Three corporate venturing windfalls have resulted in three different strategies to maximise shareholder value over the long-term.

The developing digital health sector has had to wait almost three years for the public markets to open up to it, but when they did, it was corporate venturing portfolio companies that were first through the flotation exit doors.

“WeWork’s Bonkers IPO,” said Fortune’s daily newsletter. “The Weirdness of WeWork’s IPO Filing”, sister publication CEO Daily called it, adding: “If a recession is coming, the WeWork IPO filing… will be a fitting capstone for the peak.”

Comcast has reportedly purchased over-the-top video platform Metrological, providing an exit to Liberty Global.

Pfizer spinoff Springworks, which also counts GlaxoSmithKline as an investor, secured $162m in an initial public offering that followed $228m of funding.